Article
Current and future therapies for advanced pancreatic cancer.
Journal of surgical oncology - 1 Jul 2017
Gupta Rohan, Amanam Idoroenyi, Chung Vincent
Abstract excerpt
Pancreatic cancer remains a deadly disease with a 5-year survival rate of only 8%. Even after surgical resection, most patients have recurrence of their cancer. Over the last 10 years, improvements in chemotherapy regimens led to a doubling in median overall survival. Here we review the management of advanced pancreatic cancer and highlight vaccine therapy as a novel modality of treatment.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
